Latus Bio
Discover Latus’ groundbreaking gene therapy candidates, utilizing high-throughput screened AAV capsids to transform CNS disorder treatments through precision delivery.
$97M Series A ·
Led by 8VC · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJun 10, 2022 (4 years old)
About Latus Bio
Latus’ innovative approach aims to target specific tissues, significantly enhancing safety and efficacy for patients.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $97M | fundraisingfox.com |
Timeline
- Website created
Founders and team
BL
Beverly L. Davidson FounderBM
Bethany Mancilla Chief Business OfficerJC
Jang-Ho Cha Chief Scientific Officer and Chief Marketing OfficerJC
John Connelly Chief Development OfficerKH
Katie Hewitt Interim Chief Business OfficerPP
P. Peter Ghoroghchian Chief Executive Officer
Investors
88VClead investor
BBen Franklin Technology Partners
BBioAdvance
DDCVC Bio
GGaingels
HHatch Biofund Management
HHelen’s Pink Sky Foundation
KKorea Development Bank
MModi Ventures
SSahin Boydas
Companies like Latus Bio
MManifold Bio$40M Series A · Jun 2022
YYolTech Therapeutics$45M Series B+ · Sep 2025
NNanoligent$14.01M Seed · Oct 2025
BBioOra$16.84M Series A · Oct 2026
SSomagenetixSeries A · Oct 2024
TTubulis$360M Series B+ · Oct 2025
Other companies backed by 8VC
DDren Bio$350M Series B+ · Oct 2026BBedrock Robotics$600M Series B+ · Oct 2026
HHexagon Bio$62M Series B+ · Oct 2026WWarhound$200M · Oct 2026
CCoherence Neuro$45M Series A · Oct 2026
AArda$230M · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/latus-bio (get a free API key).